Damora Therapeutics Inc (DMRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Operating Expenses | 13,552 | 11,303 | 10,166 | 6,338 | 5,830 |
| Operating Income | -13,552 | -11,303 | -10,166 | -6,338 | -5,830 |
| Other Income | 207 | -274 | -1,485 | 403 | 156 |
| Pre-tax Income | -13,345 | -11,577 | -11,651 | -5,935 | -5,674 |
| Net Income Continuous | -13,345 | -11,577 | -11,651 | -5,935 | -5,674 |
| Net Income | $-13,345 | $-11,577 | $-11,651 | $-5,935 | $-5,674 |
| EPS Basic Total Ops | -13.25 | 2,307.25 | -1,381.25 | -570.75 | -545.75 |
| EPS Basic Continuous Ops | -13.21 | 2,046.24 | -1,120.44 | -570.67 | -545.58 |
| EPS Diluted Total Ops | -13.25 | 2,307.25 | -1,381.25 | -570.75 | -545.75 |
| EPS Diluted Continuous Ops | -13.21 | 2,046.24 | -1,120.44 | -570.67 | -545.58 |
| EBITDA(a) | $-13,642 | $-11,303 | $-10,166 | $-6,338 | $-5,830 |